DE69636531T2 - METHOD, COMPOSITIONS AND KITS FOR INCREASING THE ORAL BIOVERABILITY OF PHARMACEUTICALS - Google Patents
Dossier zur Nutzenbewertung gemäß § 35a SGB V
ZBIRNI POPIS OBJAVLJENIH CIJENA LIJEKOVA za 2020. godinu Datum zadnje dopune 27.06.2021.
TWi Pharmaceuticals USA, Inc.
DE69636531T2 - METHOD, COMPOSITIONS AND KITS FOR INCREASING THE ORAL BIOVERABILITY OF PHARMACEUTICALS - Google Patents
Thieme: Fakten - Arzneimittel 2010
Praktische Hormontherapie in der Gynäkologie 5. Auflage
A14-01 - Trastuzumab Emtansin - Nutzenbewertung gemäß § 35a SGB V
HORMONSKO ZDRAVLJENJE RAKA
Medikamentenprofile – alphabetisch nach Substanzname | SpringerLink
S3-Leitlinie Endometriumkarzinom
Astrazeneca År 2006 | PDF
Exemestan Sandoz Drag 25 mg 90 Stk
Medikamente in der Tumortherapie
DE69636531T2 - METHOD, COMPOSITIONS AND KITS FOR INCREASING THE ORAL BIOVERABILITY OF PHARMACEUTICALS - Google Patents
POPIS LIJEKOVA S UTVRĐENOM NAJVIŠOM DOZVOLJENOM CIJENOM NA VELIKO U POSTUPKU GODIŠNJEG IZRAČUNA (SUKLADNO ČLANKU 188.a. ST
Swissmedic Journal 12-2013_3
oricând facultate dă jos ادوات للمطبخ شوك وملاعق inghetata Relativ mamifer
Teva Generics
Swissmedic Journal 12-2013_3
Tolterodintartrat "Teva" - information til sundhedsfaglige - Medicin.dk
oricând facultate dă jos ادوات للمطبخ شوك وملاعق inghetata Relativ mamifer
Innovationsreport 2019
